PROgressive struCturEd Simulation-based Surgical Training Program (PROCESS) - Open Vascular Surgery
PROCESS
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
A triple-arm, randomized, simple-blinded clinical trial will be conducted. A control sequence and an intervention sequence of three subgroups with different exposure levels to the simulation program are proposed. Group 1: open abdominal aortic repair (AAOR), Group 2: vascular anastomosis (VA) and AAOR, and Group 3: specific micro-surgical skills, VA and AAOR. Surgical residents of general, vascular, or cardiovascular surgery programs will be included. Sample size calculation resulted in 45 participants, 15 in each group. Simple blinding will involve external evaluators. Randomization will occur as a simple randomization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
June 11, 2024
CompletedStudy Start
First participant enrolled
July 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedJune 11, 2024
June 1, 2024
6 months
May 20, 2024
June 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy in the acquisition of technical surgical skills.
Pre- and post-intervention individual measures will be taken using the OPEn Aortic Aneurysm Repair Assessment of Technical Expertise (OPERATE) tool to compare the efficacy of the simulated program. The unit of measure are the points of OPERATE Scale with a established passing score of 27.7. A higher score means a better outcome.
4 months
Secondary Outcomes (2)
The efficacy given by the progression through the different structured modules.
4 months
The satisfaction of the residents
4 months
Study Arms (3)
Group I
EXPERIMENTALWill receive the complete structured and progressive training program involving specific micro-surgical skills, VA, and AAOR.
Group II
ACTIVE COMPARATORWill only receive VA and AAOR training.
Group III
ACTIVE COMPARATORWill only receive AAOR training.
Interventions
Participants will be exposed to different amounts of open vascular surgical training, but only group I will receive the complete structured and progressive training program. This ensures that all participants have access to the potential benefits derived from the intervention. Current evidence supports this approach, which supports the benefits of medical simulation in the training process of surgical residents.
Eligibility Criteria
You may qualify if:
- Vascular Surgery, Cardiothoracic Surgery, and General Surgery residents.
- Over 18 years old.
You may not qualify if:
- Participants who have known allergies to components of the interventions or have experienced severe adverse reactions in the past will be excluded from the study.
- Individuals who cannot provide valid informed consent due to cognitive issues, mental impairment, or legal incapacity will be excluded from the study.
- Individuals who have had prior exposure to structured simulation programs in vascular surgery will be excluded. Previous familiarity with simulation could influence study outcomes, introducing a prior learning bias that could distort the assessment of the intervention's effectiveness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Evaluators, who are external to the researchers, will be single-blinded to assess the effectiveness of different interventions. They will remain unaware of the participants' group assignments. Privacy will be maintained through coding and presenting de-identified data. Data will also be presented without voices, glove usage, and image distortion to prevent identification of personal details such as gender, race, or other characteristics.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Mandatory Social Service Medical Doctor
Study Record Dates
First Submitted
May 20, 2024
First Posted
June 11, 2024
Study Start
July 21, 2024
Primary Completion
January 15, 2025
Study Completion
January 15, 2025
Last Updated
June 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
The data may not be available for public access due to participant privacy concerns but may be available from the corresponding author upon reasonable request.